Research Study

A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Principal Investigator 
Vincent C. Ho

Overview

Body Locations and Systems 
Psoriasis
ClinicalTrials.gov# 
NCT00799877
Status 
Closed to Recruitment
Study Start/End 
Jul 6, 2009 to Jul 5, 2019
Locations 
Vancouver General Hospital
Name/Title 
Jaspal Mor, Clinical Trial Coordinator
Phone 
604-875-5296
Email Address 
jaspal.mor@ubc.ca
Purpose of Study 

The purpose of this study is to evaluate the long-term safety of Humira® in Adult Patients with Chronic Plaque Psoriasis (Ps).

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.